Charles River Laboratories
Charles River Laboratories International, Inc. is recognized as a pioneer and consistent market leader, providing a comprehensive portfolio of drug discovery and early-stage development products and services, making it a leading global supplier of animal models for biomedical research. In the Humanized Mouse Model market, CRL offers standard and highly specialized genetically engineered mice models. Their strength lies in managing strains under the International Genetic Standardization (IGS) program, ensuring researchers worldwide access standardized models with high genetic integrity and health. CRL maintains a global portfolio of high-quality immunodeficient animal models, essential for humanized immune system studies, and delivers study-ready transgenic mouse models used across nearly every therapeutic and disease research area, including oncology. By offering robust research infrastructure and end-to-end services, Charles River facilitates seamless preclinical product development and regulatory compliance, reinforcing its position as a key global partner in translational research.
Latest Market Research Report on Humanized Mouse Model Download PDF Brochure Now
The Jackson Laboratory
The Jackson Laboratory (JAX) is a leading, independent, non-profit organization renowned for its expertise in mammalian genetics and human disease research, making it a dominant force in the Humanized Mouse Model market. JAX is synonymous with innovation in mouse model genetics, maintaining an extensive repository of over 14,000 strains, including numerous immunodeficient models crucial for humanization efforts. They stand out for their commitment to data integrity and cutting-edge breeding programs, which ensure precise characterization and reproducibility required by biomedical and pharmaceutical sectors. JAX’s specialized services include Custom Model Generation and providing approximately 450 unique Patient-Derived Xenograft (PDX) oncology mouse models, which are frequently used as platforms for humanizing the tumor microenvironment for oncology research. JAX supports researchers globally by making complex genetic analysis and custom-designed models accessible, sustaining its market position by broadening offerings around disease modeling and drug discovery.
Taconic Biosciences, Inc.
Taconic Biosciences, Inc. is a leading fully integrated laboratory animal provider that excels in offering standard and custom genetically engineered rodent models (GEMs), specifically tailored for preclinical research. The company plays a significant role in the humanized mouse market, specializing in advanced models crucial for immunology, oncology, and neurobiology studies. Taconic’s flagship offerings include the NOG Portfolio, which provides highly immunodeficient models essential for engrafting human cells and tissues. They further enhance translational research through services like huSelect Services for Humanized Immune System Mice, designed to reduce variability and accelerate therapeutic development in oncology and autoimmunity research. By harmonizing industry-leading custom model generation with robust colony management solutions, Taconic provides more predictive murine models and innovative services, equipping researchers with advanced tools for accurate and translational investigations.
Biocytogen Pharmaceuticals Co., Ltd.
Biocytogen Pharmaceuticals Co., Ltd. has rapidly emerged as a critical player in the Humanized Mouse Model market, specializing in creating highly specialized models for immunology and oncology research. The company aims to bridge the “valley of death”—the gap between lab findings and clinical studies—by offering state-of-the-art humanized mouse models that go beyond traditional methods. Biocytogen offers immunodeficient mice suitable for grafting human tissues, but their proprietary strength lies in developing drug target humanized mouse models. These models are engineered by incorporating and replacing mouse genes with human ones, allowing drug candidates to bind with humanized targets in vivo. This enables critical evaluations of drug efficacy, toxicity, and accurate pharmacokinetics/pharmacodynamics (PK/PD). Utilizing next-gen gene-editing techniques and a focus on scalability, Biocytogen supports large-scale breeding to ensure consistency and reliability, accelerating the development of new treatments globally.
GenOway SA
GenOway SA is a pioneering French biotechnology company specializing in the generation of genetically engineered mouse and rat models, with a strong focus on high predictability and translational research tools for the biopharmaceutical sector. The company distinguishes itself through proprietary technology platforms that deliver advanced, highly reproducible humanized models. GenOway provides both Humanized Immune System (HIS) mice, which address human-specific questions and facilitate translational research in biomedical disciplines, and target-specific humanized mice for in vivo efficacy and safety assessment of biologics. A notable example is their hCD3 mouse model, which top pharmaceutical companies utilize to assess the efficacy of T-cell engagers (TCEs). By emphasizing regulatory-compliant, validated models and offering customized generation services, GenOway ensures ultimate predictability in preclinical models, supporting global drug discovery and development initiatives.
Latest Market Research Report on Humanized Mouse Model Download PDF Brochure Now